Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...

The Federal Trade Commission has released its second report digging into how the business practices of pharmacy benefit managers ... The report accuses CVS’ Caremark, Cigna’s Express Scripts ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

CVS Health Corporation (NYSE:CVS) offers a range of health solutions in the U.S. through three segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. It provides health ...

Currently, CVS Health has an average volume of 13.79M. TipRanks tracks over 100,000 company ... a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance ...

The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...

Nevertheless, the U.S. spends over twice as much on healthcare ... and Pharmacy Benefit Management (PBM) through Caremark. CVS Health Corporation (NYSE:CVS) also offers health services via ...